Fluorescence visualization screening for EBV-LMP1-targeted DNAzymes

Otolaryngology - Head and Neck Surgery (United States)

Volumn 150, Issue 2, 2014, Pages 251-258

  You, Xi ^a   Yang, Yu Cheng ^a   Ke, Xia ^a   Hong, Su Ling ^a   Hu, Guo Hua ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

deoxyribozyme; enhanced green fluorescent protein; Epstein Barr virus; gene therapy; latent membrane protein 1; nasopharyngeal carcinoma

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DEOXYRIBOZYME; ENHANCED GREEN FLUORESCENT PROTEIN; FLUORESCEIN ISOTHIOCYANATE; LATENT MEMBRANE PROTEIN 1; LIPOCORTIN 5; MESSENGER RNA;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; EPSTEIN BARR VIRUS; EXPRESSION VECTOR; FLUORESCENCE; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

DEOXYRIBOZYME; ENHANCED GREEN FLUORESCENT PROTEIN; EPSTEIN-BARR VIRUS; GENE THERAPY; LATENT MEMBRANE PROTEIN 1; NASOPHARYNGEAL CARCINOMA;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA, CATALYTIC; FLUORESCENT DYES; GREEN FLUORESCENT PROTEINS; HUMANS; MICROSCOPY, FLUORESCENCE; NASOPHARYNGEAL NEOPLASMS; ONCOGENE PROTEINS, VIRAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; VIRAL MATRIX PROTEINS;

EID: 84893579082     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599813514514     Document Type: Article

References (31)

1. Yoshizaki T, Ito M, Murono S, et al. Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx. 2011 ; 39: 137-144
2. Saito S, Murata T, Kanda T, et al. Epstein-Barr virus deubiquitinase down-regulates TRAF6-mediated NF-κB signaling during productive replication. J Virol. 2013 ; 87 (7). 4060-4070
3. Liu H, Zheng H, Duan Z, et al. LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells. Mol Cancer. 2009 ; 8: 92
4. Kondo S, Yoshizaki T, Wakisaka N, et al. MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling. J Virol. 2007 ; 81: 1554-1562
5. Chen J, Hu CF, Hou JH, et al. Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma. J Transl Med. 2010 ; 8: 30
6. Zheng H, Li LL, Hu DS, et al. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol. 2007 ; 4: 185-196
7. Kung CP, Meckes DG, Raab-Traub N. Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta. J Virol. 2011 ; 85: 4399-4408
8. Emilsson GM, Breaker RR. Deoxyribozymes: new activities and new applications. Cell Mol Life Sci. 2002 ; 59: 596-607
9. Benítez-Hess ML, Reyes-Gutiérrez P, Alvarez-Salas LM. Inhibition of human papillomavirus expression using DNAzymes. Methods Mol Biol. 2011 ; 764: 317-335
10. Singh N, Ranjan A, Sur S, et al. Inhibition of HIV-1 Integrase gene expression by 10-23 DNAzyme. J Biosci. 2012 ; 37: 493-502
11. Yang L, Lu Z, Ma X, Cao Y, Sun LQ. A therapeutic approach to nasopharyngeal carcinomas by DNAzymes targeting EBV LMP-1 gene. Molecules. 2010 ; 15: 6127-6139
12. Lu ZX, Ye M, Yan GR, et al. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis. Cancer Gene Ther. 2005 ; 12: 647-654
13. Ke X, Yang YC, Hong SL. EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model. Med Oncol. 2011 ; 28: 326-332
14. Lu ZX, Ma XQ, Yang LF, et al. DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma. Cancer Letters. 2008 ; 265: 226-238
15. Rossi JJ. Resurrecting DNAzymes as sequence-specific therapeutics. Sci Transl Med. 2012 ; 4: 139fs20
16. Zhanq G, Dass CR, Sumithran E, et al. Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents. J Natl Cancer Inst. 2004 ; 96: 683-696
17. Zhang J, Campbell RE, Ting AY, et al. Creating new fluorescent probes for cell biology. Nat Rey Mol Cell Biol. 2002 ; 3: 906-918
18. Arnold AS, Gueye M, Ronde P, et al. Construction of a plasmid containing human SMN, the SMA determining gene, coupled to EGF. Plasmid. 2002 ; 47: 79-87
19. Leardkamolkarn V, Sirigulpanit W. Establishment of a stable cell line coexpressing dengue virus-2 and green fluorescent protein for screening of antiviral compounds. J Biomol Screen. 2012 ; 17: 283-292
20. Uekita T, Fujii S, Miyazawa Y, Hashiguchi A, et al. Suppression of autophagy by CDCP1 signaling is essential for anchorage-independent survival of lung cancer cells. Cancer Sci. 2013 ; 104 (7). 865-870
21. Hou W, Ni Q, Wo J, et al. Inhibition of hepatitis B virus X gene expression by 10-23 DNAzymes. Antiviral Res. 2006 ; 72: 190-196
22. Heilmann AM, Calderwood MA, Portal D, Lu Y, Johannsen E. Genome-wide analysis of Epstein-Barr virus Rta DNA binding. J Virol. 2012 ; 86: 5151-5164
23. Li B, Chen Z, Liu L, et al. Differences in sensitivity to HMME-mediated photodynamic therapy between EBV+ C666-1 and EBV- CNE2 cells. Photodiagnosis Photodyn Ther. 2012 ; 7: 204-209
24. Zaborowska Z, Schubert S, Kurreck J, et al. Deletion analysis in the catalytic region of the 10-23 DNA enzyme. FEBS Lett. 2005 ; 579: 554-558
25. Ren N, Wang F, Niu JQ. A study of 10-23 DNAzyme inhibiting the expression of hepatitis B virus genes. Chin J Hepatol. 2005 ; 13: 745-748
26. Kaye KM, Izumi KM, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Sci. 1993 ; 90: 9150-9154
27. Diduk SV, Smirnova KV, Pavlish OA, et al. Functionally significant mutations in the Epstein-Barr virus LMP1 gene and their role in activation of cell signaling pathways. Biochemistry(Mosc). 2008 ; 73: 1134-1139
28. Bentz GL, Whitehurst CB, Pagano JS, et al. Epstein-Barr virus latent membrane protein 1 (lmp1) c-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9. J Virol. 2011 ; 85: 10144-10153
29. Nawrot B, Widera K, Sobczak M, et al. Effect of R-P and S(P)phosphorothioate substitution at the scissile site on the cleavage activity of deoxyribozyme 10-23. Current Organic Chemistry. 2008 ; 12: 1004-1009
30. Zaborowska Z, Furste JP, Erdmann VA, et al. Sequence requirements in the catalytic core of the "10-23" DNA enzyme. J Biol Chem. 2002 ; 277: 40617-40622
31. Cai H, Santiaqo FS, Prado-Lourencol L, et al. DNAzyme targeting c-jun suppresses skin cancer growth. Sci Transl Med. 2012 ; 4: 139ra82